D. E. Shaw & Co., Inc. Repare Therapeutics Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 120,133 shares of RPTX stock, worth $468,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,133
Previous 77,179
55.66%
Holding current value
$468,518
Previous $563,000
0.36%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RPTX
# of Institutions
77Shares Held
38.4MCall Options Held
66.4KPut Options Held
2.7K-
Bvf Inc San Francisco, CA10.3MShares$40.3 Million1.46% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$13 Million0.35% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.12MShares$12.2 Million3.9% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$11.6 Million17.66% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.7MShares$10.5 Million0.09% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $164M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...